The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
“The IHE is delighted to welcome Rob Seidel as Board Chair,” said Dr. McCabe, the IHE’s CEO and Executive Director. “Rob Seidel’s extensive experience in board governance and in leading health-related organizations such as Alberta Innovates – Health Solutions has clearly demonstrated his significant expertise and commitment to developing successful partnerships and collaborations…
The Institute of Health Economics (IHE) and Applied Pharmaceutical Innovation (API) are creating value through collaboration. The IHE and API have signed a Memorandum of Understanding (MOU) in the field of economic analysis and health technology assessment to support each other’s aspiration in the development of a broader, stronger, and more vibrant innovation ecosystem. “Successful…
L'IHE, le Centre de recherche de l'Institut universitaire en santé mentale de Montréal et l'Université de Montréal ont le plaisir d'annoncer la publication de IHE SÉSaMe 2019 – un manuel virtuel de statistiques économiques sur la santé mentale qui résume les données les plus récentes disponibles concernant les indicateurs ayant une incidence sur les divers aspects économiques du…
The IHE, the Centre de recherche de l’Institut universitaire en santé mentale de Montréal, and the Université de Montréal are pleased to announce the release of IHE Mental Health In Your Pocket 2019 – a virtual handbook of mental health economic statistics that synthesizes the most current, available data on indicators that affect the various economic aspects of the Canadian mental…
The IHE is pleased to have partnered with Abbott and other global health industry leaders to launch the UNIVANTS of Healthcare Excellence award. This annual award honours integrated, multidisciplinary clinical care teams with innovative approaches to achieve measurably better healthcare performance for patients, clinicians, payers, and healthcare institutions. The UNIVANTS of Healthcare…
The IHE is delighted to have provided support to CASA for the very popular and well-attended Dr. Roger Bland Community Lecture Series. This mini-series addressed important issues in children’s mental health, with each event featuring a keynote speaker and an expert panel to lead the conversation and answer audience questions. Each of these free events welcomed everyone to attend…
In this photo (from left): Dr. Arto Ohinmaa (University of Alberta), Dr. Mike Paulden (University of Alberta), Ryan Au (Award Winner), Ryan Fung (Award Winner), Julia Dabravolskaj (Award Winner), Carla Ickert (Award Winner), Dr. Christopher McCabe (IHE) The IHE is delighted to congratulate Ryan Au, Julia Dabravolskaj, Ryan Fung, and Carla Ickert of the University of Alberta as…
In this photo (from left): Dr. Mingshan Lu (University of Calgary), Dr. Christopher McCabe (IHE), Eashita Dabas (Award Winner), Kolawole Adedapo (Award Winner), Melanie Varkey (Award Winner), Dr. Jeff Round (IHE). Missing (inset): Anuj Sharma (Award Winner) The IHE is delighted to congratulate Kolawole Adedapo, Eashita Dabas, Anuj Sharma, and Melanie Varkey of the University of…
| Michelle Pollock, Ann Scott, Jennifer Seida, Paula Corabian, Andrew J. Sutton, Mike Paulden, Christopher McCabe, Lisa Tjosvold, Bing Guo
The clinical review and economic evaluation aimed to determine how Oncotype DX and Prosigna can be optimally used to determine which patients with early-stage breast cancer will benefit from adjuvant chemotherapy. This report addresses the following research question: For patients with early-stage (I–III), ER+, HER2?, node-negative or node-positive (one to three nodes) breast…
29 May 2019 Edmonton, Alberta On May 29, 2019, the Institute of Health Economics (IHE), the Network of Alberta Health Economists (NOAHE) and the Alberta Real World Evidence Consortium (Alberta RWE) were delighted to host Prof Annette Braunack-Mayer of the University of Wollongong, Australia, who discussed the social and ethical issues related to the collection and use of real world…
Due to positive response to the IHE’s Health Economics Educational Workshop held in Calgary and Edmonton in November 2018, the IHE is now offering an online edition – the IHE Health Economics Virtual Workshop. The IHE Health Economics Virtual Workshop is a free, online workshop for small- and medium-sized life science companies. This online course is designed to help participants…
Primary Care Low Back Exam factsheet - 2006.
Extracted from the Chronic Pain Management Binder November 2005.
Link to Alberta Ambassador Guideline Adaptation Program
27 November 2014 Edmonton, Alberta Health System Standards: From Good Intent to Real World Application is the 12th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Key Forum Documents Innovation Forum XII – Health System Standards: From Good Intent to Real World…
Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference 23 November 2014 Edmonton, Alberta This free forum for primary care clinicians was held in conjunction with the annual Accelerating Primary Care conference in Edmonton, Alberta, November 23, 2014. The forum saw three physician leaders review the latest developments in the…
17 November 2014 Ottawa, Ontario The federal Ministry of Health (Health Canada) announced the creation of the Advisory Panel on Healthcare Innovation on June 24, 2014, to examine innovative health care ideas and approaches that exist in Canada and internationally. The Panel’s directive is to determine what approaches hold the greatest potential for Canadians and to create…
2 November 2014 Toronto, Ontario In April 2014, we held the first roundtable discussion on the current and future role of real world evidence (RWE) in Canada, bringing together multiple stakeholders from across Canada and internationally. Workshop participants felt there was much more to explore in future discussion and a specific need was identified to focus part of future conversations…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the clinical effectiveness and safety of hysteroscopic tubal sterilization, and the value for money associated with adopting hysteroscopic tubal sterilization in Alberta. Section Authors: Section One – Background and Context: Carmen…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the best available research evidence on the safety and effectiveness, cost effectiveness and budget impact of using Endovenous Laser Ablation (EVLA) or Endovenous Radiofrequency Ablation (RFA) in the management of symptomatic varicose…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the safety, screening accuracy, therapeutic efficacy, patient outcomes and cost effectiveness of first trimester Quad (1T-Quad) +/- NT and NIPT screening for fetal trisomies. Section Authors: Section One – Technology Effectiveness and Safety: Ken Bond,…
18 – 20 June 2014 Calgary, Alberta The 3-day Canadian Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) held in Calgary, Alberta from June 18 – 20, 2014, was the first event of its kind to look at issues in the field of AROs. Download Consensus Statement The Consensus Conference model is an exciting format, geared to creating…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the potential role of low dose computed tomography (LDCT) in screening for lung cancer in adults aged 50 years or older in Alberta. Section Authors: Section One – Social and System Demographics Analysis: Bing Guo, Dagmara Chojecki Section Two –…
Thursday, 29 May 2014 Edmonton, Alberta The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Key Symposium Documents Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care – Symposium ProgramDownload Program Rheumatoid Arthritis…
27 May 2014 Edmonton, Alberta Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Key Forum Documents Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care – FINAL PROGRAMDownload…
This report has been produced in response to a request from Alberta Health (AH). The objective was to perform a review of practices of engaging committees composed of lay people or members of the general public at international, national, provincial, and regional levels. The review attempts to address the following questions: What scientific evidence is available about committees…
| Sue Ludwig, Patricia Leggett Tait, Christa Harstall
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #22. This review was requested to determine whether conductive education as a learning approach or therapeutic intervention is safe and efficacious for children with disabilities such as cerebral palsy that impact neuromotor functioning. The review also addresses the profile of the child who would benefit from…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #21. The three objectives of this assessment are to determine the available scientific evidence on: the effective time interval for mammography screening in asymptomatic women aged 50 to 69 years; the effective screening interval in asymptomatic women between the ages of 40 and 49 years; and the mortality rate…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #18. This report has been prepared following interest by the Alberta Cord Blood Bank in obtaining advice on the comparative effectiveness and costs of different types of stem cell transplantation. Earlier assessments by the Foundation have considered peripheral blood stem cell transplantation and cord blood transplantation.…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #1. This report has been prepared to provide information and assist discussion on the management of pressure sores, a significant source of morbidity in health care institutions. The focus of the report is on a specific technology, interface pressure measurement. It is expected that other issues in this are will…